Effect of intravitreal bevacizumab injection before vitrectomy on proliferative diabetic retinopathy
Author:
Corresponding Author:

Affiliation:

Clc Number:

R779.6

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    AIM:To evaluate the effect of intravitreal bevacizumab (IVB) injection 1 week before pars plana vitrectomy (PPV) in proliferative diabetic retinopathy (PDR) patients. ·METHODS:A retrospective research was done on 46 PDR patients who were divided into PPV group (n=28) and IVB group (n=18,PPV with preoperative IVB). Bevacizumab was injected 1 week before PPV. Main outcome measures were visual acuity,incidence of iatrogenic retinal breaks,intraoperative and postoperative bleeding. ·RESULTS:At 1 month after surgery,visual acuity in PPV (82.1%) and IVB group (88.9%) improved significantly (P<0.01) and the difference between the two groups was not significant. Iatrogenic retinal breaks were reported in 18 cases (64.3%) in PPV group and 4 cases (22.2%) in IVB group (P<0.05). Intraoperative bleeding was encountered in all cases in PPV group and 7 cases (39%) in IVB group (P<0.01). Postoperative bleeding was reported in 9 cases (32.1%) in PPV group and none in IVB group (P<0.01). ·CONCLUSION:IVB injection before PPV is helpful in reducing iatrogenic retinal breaks,intraoperative and postoperative bleeding in PDR patients.

    Reference
    Related
    Cited by
Get Citation

Cai-Rui Li, Shu-Guang Sun, Wei Hong. Effect of intravitreal bevacizumab injection before vitrectomy on proliferative diabetic retinopathy. Guoji Yanke Zazhi( Int Eye Sci) 2010;10(9):1654-1656

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:
  • Revised:
  • Adopted:
  • Online:
  • Published: